Evidence map›Paper›PMID 42711138›Full record

ArticleChemphyschem : a European journal of chemical physics and physical chemistry2026

Integrating Low-Cost xTB Electronic Priors for Predicting Electronic and Excited-State Properties of Organic Conjugated Molecules.

Min Zeng, Lian Huai, Tong Liu, Yuyu Liu, Xingqun Jiang

Abstract read
In one paragraph

Article in Chemphyschem : a European journal of chemical physics and physical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Min ZengBOE Technology Group Co., Ltd., Beijing, China.ORCID https://orcid.org/0000-0002-7935-4236
Lian HuaiBOE Technology Group Co., Ltd., Beijing, China.
Tong LiuBOE Technology Group Co., Ltd., Beijing, China.ORCID https://orcid.org/0009-0003-5897-0720
Yuyu LiuBOE Technology Group Co., Ltd., Beijing, China.
Xingqun JiangBOE Technology Group Co., Ltd., Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurate prediction of electronic and excited-state properties is important for the computational screening of organic conjugated molecules. However, this task remains challenging because these properties depend on both local chemical environments and global structural and electronic information. In this work, we develop a dual-tower molecular representation framework that combines a graph tower for local atom-bond connectivity with a global tower for global structural information and extended tight-binding (xTB)-derived electronic priors. Evaluated on the OCELOT chromophore dataset, the fusion of graph representations with global structural features consistently outperforms the graph-only baseline. Incorporating xTB descriptors into the global tower further reduces the average MAE. The best fusion model reaches an average MAE of 0.148 ± 0.001 eV compared with 0.156 ± 0.002 eV for the graph-only model. Ablation studies across different fusion strategies show that the main benefit arises from combining local atom-bond connectivity information with global molecule-level information rather than from any single fusion operator. These results demonstrate that global representations combining RDKit descriptors, Morgan fingerprints, and xTB-derived electronic descriptors provide useful support for graph neural networks (GNNs) to predict electronic and excited-state properties of organic conjugated molecules.

Indexed as

extended tight‐binding (xTB)graph–global fusionorganic conjugated moleculesproperty prediction

Identifiers

PMID42711138
PMCPMC13553210

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.